HRCT Findings ofBleomycin-Related Lung Toxicity : A Report of 2 Cases 1

Many drugs can result in a variety of pathologic reactions in the lung , especially the cytotoxic drugs. Among cytotoxic drugs bleomycin is a prototype. Bleomycin-related pulmonary toxicity is usually known as dose-dependent and can be enhanced with concurrent oxygen therapy , irradiation , or other chemotherapeutic agents. The inci dence of bleomycin-induced pulmonary toxicity has been reported as varying from 2 to 46 %, and 1 % offatallung disease. We describe the radiographic and HRCT findings of bleomycin-related pulmonary toxicity developed in two patients: one in ovarian teratocarcinoma , the other malignant lymphoma patient. Chest radiographs and HRCT of these patients showed ground-glass opacities , consolidation , linear and reticular opacities , and interlobular septal thicken ing. These abnormalities were bilateraL and symmetrical and were found predominantly in the area ofmid- and lower-lung zone.

[1]  P. Herman,et al.  Bleomycin-induced fibrosis in pigs: evaluation with CT. , 1994, Radiology.

[2]  J. Husband,et al.  Computed tomography of pulmonary bleomycin toxicity. , 1990, Seminars in ultrasound, CT, and MR.

[3]  K. Sikora,et al.  Bleomycin lung: computed tomographic observations. , 1985, The British journal of radiology.

[4]  J. Husband,et al.  Bleomycin-related lung damage: CT evidence. , 1985, Radiology.

[5]  M. Jochelson,et al.  Pulmonary complications of chemotherapy regimens containing bleomycin. , 1982, AJR. American journal of roentgenology.

[6]  T. Takeuchi,et al.  New antibiotics, bleomycin A and B. , 1966, The Journal of antibiotics.

[7]  R. Matthay,et al.  Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. , 1986, The American review of respiratory disease.